Ablevia biotech GmbH
Back to list
Facts
- Founded
- 2018
- Staff
- 4
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
Ablevia develops a new class of infusible therapeutics to selectively remove harmful and disease-causing antibodies. These therapeutics can be readily adapted to target unwanted antibodies in rare diseases or in conditions with unmet clinical needs. Founded in 2018 at the Vienna Biocenter Campus, Ablevia focuses on IP generation and preclinical research and development.
R&D:Ablevia focusses on research and development of therapeutics for the selective removal of disease-causing and harmful anitbodies in autoimmune diseases or neutralizing anti-drug anitbodies.
Similar companies in RDM biotech/pharma
pharm-analyt Labor GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- ecoplus
- Focus
- non-specific applications
P4 Therapeutics GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
OrthoSera GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- ecoplus
- Focus
- human health
InvIOs GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna